It seems like you are using an older browser, please update your browser for a better user experience.

Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.

Investor Overview

Corporate Profile

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

PRESS RELEASES More »

Toggle Summary Stryker Corporation named one of Fortune Magazine's 100 Best Companies to Work For for eighth consecutive year
Kalamazoo, Michigan - February 15, 2018 - Stryker Corporation (NYSE:SYK) announced today that it has been named one of Fortune's 2018 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States . The list recognizes companies that have exceptional
Toggle Summary Stryker crosses the 95% thresholds in VEXIM and announces its intention to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM
Kalamazoo, Michigan - February 14, 2018 - Stryker Corporation (NYSE:SYK) announced that it has crossed the 95% thresholds in VEXIM and intends to file a proposed public buy-out offer followed by a squeeze-out for the outstanding shares of VEXIM , in accordance with French tender offer laws and
Toggle Summary Stryker declares a $0.47 per share quarterly dividend
Kalamazoo, Michigan - February 7, 2018 - Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.47 per share payable on April 30, 2018 to shareholders of record at the close of business on March 29, 2018 , representing an increase of
Toggle Summary Stryker reports 2017 results and 2018 outlook
Kalamazoo, Michigan - January 30, 2018 - Stryker Corporation (NYSE:SYK) reported 2017 operating results for the fourth quarter and full year and 2018 outlook: Fourth Quarter Highlights Net sales grew 10.0% to $3.5 billion (8.7% constant currency) Orthopaedics 8.1 % or 6.8 % constant currency

UPCOMING EVENTS More »

There are currently no events to display.

RECENT EVENTS More »

Investor Contacts
Katherine A. Owen
Vice President, Strategy & Investor Relations
Stryker Corporation
2825 Airview Boulevard
Kalamazoo, MI 49002
269-385-2600